79 related articles for article (PubMed ID: 29110262)
21. PD-1 blockade in advanced NSCLC: A focus on pembrolizumab.
Peters S; Kerr KM; Stahel R
Cancer Treat Rev; 2018 Jan; 62():39-49. PubMed ID: 29156447
[TBL] [Abstract][Full Text] [Related]
22. Immune checkpoint inhibitors: new strategies to checkmate cancer.
Wilson RAM; Evans TRJ; Fraser AR; Nibbs RJB
Clin Exp Immunol; 2018 Feb; 191(2):133-148. PubMed ID: 29139554
[TBL] [Abstract][Full Text] [Related]
23. Arthritis After Cancer Immunotherapy: Symptom Duration and Treatment Response.
Smith MH; Bass AR
Arthritis Care Res (Hoboken); 2019 Mar; 71(3):362-366. PubMed ID: 29125905
[TBL] [Abstract][Full Text] [Related]
24. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part II-The Challenge of Programmed Death Ligand-1 Testing and Its Role in Microsatellite Instability-High Colorectal Cancer.
Marginean EC; Melosky B
Arch Pathol Lab Med; 2018 Jan; 142(1):26-34. PubMed ID: 29120224
[TBL] [Abstract][Full Text] [Related]
25. Platelet-related indices in patients with lung cancer with nivolumab.
Nomura S; Yokoi T; Kurata T
Platelets; 2018 Mar; 29(2):207-208. PubMed ID: 29119852
[No Abstract] [Full Text] [Related]
26. Synergistic anticancer activity of a novel oral chemotherapeutic agent containing trifluridine and tipiracil in combination with anti-PD-1 blockade in microsatellite stable-type murine colorectal cancer cells.
Suzuki N; Tsukihara H; Nakagawa F; Kobunai T; Takechi T
Am J Cancer Res; 2017; 7(10):2032-2040. PubMed ID: 29119052
[TBL] [Abstract][Full Text] [Related]
27. The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma.
Heymann MF; Lézot F; Heymann D
Cell Immunol; 2019 Sep; 343():103711. PubMed ID: 29117898
[TBL] [Abstract][Full Text] [Related]
28. Smoking and EGFR status may predict outcomes of advanced NSCLC treated with PD-(L)1 inhibitors beyond first line: A meta-analysis.
Abdel-Rahman O
Clin Respir J; 2018 May; 12(5):1809-1819. PubMed ID: 29115057
[TBL] [Abstract][Full Text] [Related]
29. Infiltration of metastatic lymph nodes with PD-1
Wang S; Song Y; Morse MA; Sun P; Qiao G; Wang X; Zhou X; Hobeika A; Ren J; Lyerly HK
Am J Cancer Res; 2020; 10(12):4435-4449. PubMed ID: 33415009
[TBL] [Abstract][Full Text] [Related]
30. Intratumor heterogeneity: A new perspective on colorectal cancer research.
Zheng Z; Yu T; Zhao X; Gao X; Zhao Y; Liu G
Cancer Med; 2020 Oct; 9(20):7637-7645. PubMed ID: 32853464
[TBL] [Abstract][Full Text] [Related]
31. Prognostic classifications of lymph node involvement in lung cancer and current International Association for the Study of Lung Cancer descriptive classification in zones.
Riquet M; Arame A; Foucault C; Le Pimpec Barthes F
Interact Cardiovasc Thorac Surg; 2010 Sep; 11(3):260-4. PubMed ID: 20573650
[TBL] [Abstract][Full Text] [Related]
32. [Routine high-throughput targeted sequencing of lymphoproliferative diseases : Clinical utility and challenges].
Menter T; Dirnhofer S; Tzankov A
Pathologe; 2020 Dec; 41(Suppl 2):143-148. PubMed ID: 33270163
[TBL] [Abstract][Full Text] [Related]
33. Mutational Diversity of Lung Cancer and Associated Lymph Nodes. An Exploratory Prospective Study of 4 Resected cIIIA-N2.
Legras A; Roussel H; Mangiameli G; Arame A; Grand B; Pricopi C; Badia A; Gibault L; Badoual C; Fabre E; Laurent-Puig P; Blons H; Le Pimpec-Barthes F
Pathol Oncol Res; 2019 Jan; 25(1):319-325. PubMed ID: 29110262
[TBL] [Abstract][Full Text] [Related]
34. Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinoma.
Yip PY; Yu B; Cooper WA; Selinger CI; Ng CC; Kennedy CW; Kohonen-Corish MR; McCaughan BC; Trent RJ; Boyer MJ; Kench JG; Horvath LG; O'Toole SA
J Thorac Oncol; 2013 Apr; 8(4):408-14. PubMed ID: 23392229
[TBL] [Abstract][Full Text] [Related]
35. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
36. Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.
Malapelle U; Mayo de-Las-Casas C; Rocco D; Garzon M; Pisapia P; Jordana-Ariza N; Russo M; Sgariglia R; De Luca C; Pepe F; Martinez-Bueno A; Morales-Espinosa D; González-Cao M; Karachaliou N; Viteri Ramirez S; Bellevicine C; Molina-Vila MA; Rosell R; Troncone G
Br J Cancer; 2017 Mar; 116(6):802-810. PubMed ID: 28170370
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]